Katja Stout

Managing Director at Scius Communications

Speaker

Katja is a communications strategist and entrepreneur with over twenty years of international experience in the life sciences and pharmaceutical industry. As Managing Director and Founder of Scius Communications, Katja supported Immunocore’s $320 million financing, Europe’s largest-ever private round in life sciences. She has recently worked on investor decks for Pharnext and Pneumagen and is also working with Oxford Biomedica, Consilient Health and Novo Nordisk to support their business development efforts with potential partners.

Katja co-founded Northbank communications, a leading global specialist life sciences communications firm, and supported the company’s growth to over 35 staff and 100 clients prior to its successful sale to College Hill (now Instinctif). Subsequently, Katja spent four years at AstraZeneca firstly as Director of Partnering Communications in the business development team and supported AZ’s notable rise in the industry league tables from number 12 to number 3 as the ‘partner of choice’. She later became Vice President of Corporate Affairs, Global Product and Portfolio Strategy (GPPS) and was a member of the GPPS leadership team.

Katja has a Masters degree in Biochemistry from Oxford University and an MBA from Imperial College London.